Should a psychiatrist give the ‘special patient’ VIP treatment?
The influence of medications on neurocognition in bipolar disorder
Amisulpride – dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring
Treatment-resistant bipolar depression: towards a new definition
Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial
Is bipolar II depression phenotypically distinctive?
The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ
Gender differences in bipolar disorder type I and II
Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology
White matter lesions in euthymic patients with bipolar disorder
Birth-cohort and dual diagnosis effects on age-at-onset in Brazilian patients with bipolar I disorder
Subjective quality of life aspects predict depressive symptoms over time: results from a three-wave longitudinal study
The ‘boon and bane’ of antipsychotic-induced metabolic syndrome
The ‘boon and bane’ of antipsychotic-induced metabolic syndrome
Law 180 after 30 years – reflections on unmet needs and risks of loss of identity for Italian psychiatrists
Psychostimulants and treatment resistant depression
Psychostimulants and treatment resistant depression
Biography
Biography